Feeds:
Posts
Comments

Posts Tagged ‘catheterisation’

URO TODAY: The bone-anchored male sling is an effective and minimally invasive treatment for mild-to-moderate male urinary incontinence, according to a new study. READ MORE>

Read Full Post »

MARKETWIRE:  The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>

Read Full Post »

BBC NEWS: A BRCA2 gene mutation can increase risk of prostate cancer by up to seven-fold, while a BRACA1 mutation is thought to double risk in men under 65 years old, a study shows. READ MORE>

Read Full Post »

URO TODAY: A more precise grading system is needed to predict men’s erectile function recovery after nerve-sparing prostate surgery, a study shows. READ MORE>

Our data support the adoption of a subjectively assigned nerve-sparing score to more precisely predict erectile function outcomes and suggest that even minor nerve trauma significantly impairs the recovery of erectile function after procedures classically regarded as having achieved bilateral nerve sparing.

Further studies are needed to identify the optimal nerve-sparing system.

Read Full Post »

URO TODAY:  Having a low carb diet is as good as a no-carb one when it comes to surviving prostate cancer, tests on mice have shown. READ MORE>

Previous studies indicate that carbohydrate intake influences prostate cancer biology, as mice fed a no-carbohydrate ketogenic diet had significantly smaller tumours and longer survival than mice fed a Western diet.

As it is nearly impossible for humans to consume and maintain a no-carbohydrate ketogenic diet, we determined whether diets containing 10% or 20% carbohydrate kcal showed similar tumor growth as NCKD.

Read Full Post »

URO TODAY: The WASF3 protein plays a critical role in the progression of prostate cancer and is a potential target to control tumorigenicity and metastasis. READ MORE>

Read Full Post »

URO TODAY: Men with metabolic syndrome – obesity/heart disease/diabetes – have a greater risk of getting prostate cancer, especially if they suffered from the syndrome by the time they turned 50, scientists have discovered. READ MORE>

Men having metabolic syndrome had a modestly higher risk of developing prostate cancer than men not having MetS criteria.

The conditional probability of being diagnosed with prostate cancer age 80 years was statistically significantly higher in men with MetS at age 50 years.

Read Full Post »

« Newer Posts - Older Posts »